EGFR and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), YTHDF2 has a dual role: it increases the stemness and tumor growth of liver cancer stem cells (LCSCs) by increasing the translation of OCT4, but it also inhibits the proliferation and growth of HCC cells by decreasing the stability of EGFR.72